Regarding the immune inhibitors, HAVCR2, LAG3, LGALS9, and PVRL2 were significantly more highly expressed in GBM samples compared with nontumor samples, while CD244 and IDO1 showed an opposite expression pattern (Figure 6B). This evidence concerns the gene LAG3 and glioblastoma.